久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/16 | 8,690 | 8,890 | 8,680 | 8,780 | -20 | -0.2% | 119,800 |
2018/05/15 | 8,900 | 8,980 | 8,780 | 8,800 | ±0 | ±0% | 147,900 |
2018/05/14 | 8,750 | 8,880 | 8,670 | 8,800 | +150 | +1.7% | 151,700 |
2018/05/11 | 8,610 | 8,810 | 8,600 | 8,650 | +20 | +0.2% | 155,600 |
2018/05/10 | 8,590 | 8,660 | 8,480 | 8,630 | -20 | -0.2% | 147,400 |
2018/05/09 | 8,790 | 8,800 | 8,600 | 8,650 | -250 | -2.8% | 191,900 |
2018/05/08 | 8,910 | 8,990 | 8,830 | 8,900 | +140 | +1.6% | 191,600 |
2018/05/07 | 8,620 | 8,760 | 8,570 | 8,760 | +160 | +1.9% | 159,000 |
2018/05/02 | 8,540 | 8,620 | 8,450 | 8,600 | -30 | -0.3% | 111,000 |
2018/05/01 | 8,450 | 8,640 | 8,400 | 8,630 | +100 | +1.2% | 138,000 |
2018/04/27 | 8,500 | 8,730 | 8,440 | 8,530 | +100 | +1.2% | 224,000 |
2018/04/26 | 8,330 | 8,460 | 8,240 | 8,430 | +250 | +3.1% | 241,100 |
2018/04/25 | 7,970 | 8,250 | 7,970 | 8,180 | +160 | +2% | 133,300 |
2018/04/24 | 7,930 | 8,040 | 7,900 | 8,020 | +150 | +1.9% | 113,200 |
2018/04/23 | 7,920 | 7,990 | 7,840 | 7,870 | -60 | -0.8% | 96,600 |
2018/04/20 | 7,800 | 7,990 | 7,770 | 7,930 | +60 | +0.8% | 127,000 |
2018/04/19 | 8,080 | 8,080 | 7,870 | 7,870 | -180 | -2.2% | 118,800 |
2018/04/18 | 8,050 | 8,070 | 7,960 | 8,050 | +90 | +1.1% | 95,200 |
2018/04/17 | 7,920 | 8,030 | 7,900 | 7,960 | -10 | -0.1% | 121,000 |
2018/04/16 | 7,680 | 8,050 | 7,650 | 7,970 | +370 | +4.9% | 173,500 |
2018/04/13 | 7,770 | 7,770 | 7,570 | 7,600 | -180 | -2.3% | 213,100 |
2018/04/12 | 8,090 | 8,110 | 7,760 | 7,780 | -280 | -3.5% | 271,400 |
2018/04/11 | 8,110 | 8,220 | 7,830 | 8,060 | -480 | -5.6% | 387,900 |
2018/04/10 | 8,600 | 8,690 | 8,440 | 8,540 | -90 | -1% | 149,700 |
2018/04/09 | 8,550 | 8,700 | 8,480 | 8,630 | +120 | +1.4% | 168,800 |
2018/04/06 | 8,380 | 8,580 | 8,340 | 8,510 | +130 | +1.6% | 215,300 |
2018/04/05 | 8,280 | 8,500 | 8,220 | 8,380 | +230 | +2.8% | 172,000 |
2018/04/04 | 8,150 | 8,190 | 8,050 | 8,150 | ±0 | ±0% | 107,000 |
2018/04/03 | 8,050 | 8,200 | 7,970 | 8,150 | ±0 | ±0% | 109,100 |
2018/04/02 | 8,220 | 8,290 | 8,140 | 8,150 | -90 | -1.1% | 93,500 |
2018/03/30 | 8,230 | 8,250 | 8,100 | 8,240 | +100 | +1.2% | 125,500 |
2018/03/29 | 8,170 | 8,270 | 8,050 | 8,140 | +160 | +2% | 194,800 |
2018/03/28 | 7,860 | 7,980 | 7,780 | 7,980 | +80 | +1% | 130,700 |
2018/03/27 | 7,810 | 7,920 | 7,760 | 7,900 | +180 | +2.3% | 172,600 |
2018/03/26 | 7,650 | 7,740 | 7,630 | 7,720 | -20 | -0.3% | 149,900 |
2018/03/23 | 7,940 | 8,000 | 7,710 | 7,740 | -470 | -5.7% | 201,100 |
2018/03/22 | 8,050 | 8,230 | 8,000 | 8,210 | +110 | +1.4% | 121,200 |
2018/03/20 | 8,080 | 8,170 | 8,010 | 8,100 | -100 | -1.2% | 156,100 |
2018/03/19 | 8,140 | 8,250 | 8,060 | 8,200 | +10 | +0.1% | 161,600 |
2018/03/16 | 7,950 | 8,280 | 7,950 | 8,190 | +270 | +3.4% | 292,400 |
2018/03/15 | 7,980 | 8,000 | 7,830 | 7,920 | -10 | -0.1% | 124,600 |
2018/03/14 | 7,800 | 7,950 | 7,690 | 7,930 | +180 | +2.3% | 200,000 |
2018/03/13 | 7,640 | 7,760 | 7,640 | 7,750 | +60 | +0.8% | 86,300 |
2018/03/12 | 7,650 | 7,700 | 7,520 | 7,690 | +150 | +2% | 136,800 |
2018/03/09 | 7,550 | 7,740 | 7,510 | 7,540 | +100 | +1.3% | 204,500 |
2018/03/08 | 7,530 | 7,590 | 7,420 | 7,440 | +60 | +0.8% | 114,300 |
2018/03/07 | 7,320 | 7,500 | 7,320 | 7,380 | -40 | -0.5% | 106,300 |
2018/03/06 | 7,420 | 7,510 | 7,370 | 7,420 | +70 | +1% | 124,700 |
2018/03/05 | 7,260 | 7,450 | 7,250 | 7,350 | +60 | +0.8% | 127,700 |
2018/03/02 | 7,330 | 7,370 | 7,250 | 7,290 | -240 | -3.2% | 146,000 |
1701~
1750
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム